This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (26) Citing Articles via Google Scholar Google Scholar Articles by Grayburn, P. A. Search for Related Content PubMed PubMed Citation Articles by Grayburn, P. A.

Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure

The Beta-blocker Evaluation of Survival Trial (BEST)

Paul A. Grayburn, MD^_*,_*, Christopher P. Appleton, MD, Anthony N. DeMaria, MD, Barry Greenberg, MD, Brian Lowes, MD, Jae Oh, MD^||, Jonathan F. Plehn, MD^¶, Peter Rahko, MD^#, Martin St. John Sutton, MD^_**, Eric J. Eichhorn, MD^_* the BEST Trial Echocardiographic Substudy Investigators

^_* Echocardiographic Core Laboratory, Baylor University Medical Center, Dallas, Texas
Mayo Clinic Scottsdale, Scottsdale, Arizona
University of California, San Diego, San Diego, California
University of Colorado, Denver, Colorado
^|| Mayo Clinic Rochester, Rochester, Minnesota
^¶ National Heart, Lung, and Blood Institute, Washington, DC
^# University of Wisconsin, Madison, Wisconsin
^_** University of Pennsylvania, Philadelphia, Pennsylvania

View larger version (12K): [in a new window]   Figure 1 Kaplan-Meier plot showing time to death by left ventricular (LV) end-diastolic volume index. Patients are stratified according to LV end-diastolic volume index 120 ml/m2 versus >120 ml/m2. E = events.

View larger version (18K): [in a new window]   Figure 2 Kaplan-Meier plots showing time to the combined end point of death, heart failure hospitalization, or transplant for patients with a left ventricular end-diastolic volume index (LVEDVI) 120 ml/m2 versus >120 ml/m2 (top panel), a mitral deceleration time (DT) 150 ms versus <150 ms (middle panel), and a mitral regurgitation vena contracta width (VCW) of 0.4 cm versus >0.4 cm (bottom panel). Variables included in the model were LVEDVI, mitral DT, and mitral regurgitation VCW. E = events.